Anchorage-independent growth is the ability of transformed cells to grow independently of a solid surface, and is a hallmark of carcinogenesis. The soft agar colony formation assay is a well-established method for characterizing this capability in vitro and is considered to be one of the most stringent tests for malignant transformation in cells. This assay also allows for semi-quantitative evaluation of this capability in response to various treatment conditions. Here, we will demonstrate the soft agar colony formation assay using a murine lung carcinoma cell line, CMT167, to demonstrate the tumor suppressive effects of two members of the Wnt signaling pathway, Wnt7A and Frizzled-9 (Fzd-9). Concurrent overexpression of Wnt7a and Fzd-9 caused an inhibition of colony formation in CMT167 cells. This shows that expression of Wnt7a ligand and its Frizzled-9 receptor is sufficient to suppress tumor growth in a murine lung carcinoma model.
Introduction
The soft agar colony formation assay is a technique widely used to evaluate cellular transformation in vitro. Historically, another assay, the clonogenic assay, described by Puck et al. in 1956 was used to evaluate the ability of cells to form colonies 1 . In this technique, cells were dispersed onto a culture plate and grown in the presence of 'feeder' cells or conditioned medium to provide necessary growth factors. The limitation of this technique was that it only provided information regarding colony formation. Normal cells are prevented from anchorageindependent growth, due to a particular type of apoptotic death, called anoikis 2 . However, transformed cells have the capability to grow and divide without binding to a substrate. To capitalize on this concept, researchers developed the soft agar colony formation assay. The soft agar colony formation assay has since been modified, in more recent years, to address specific needs. One variation involves incorporation of fluorometric dye to allow for high-throughput colony counting. Another variation involves the use of specialized agar solution to allow for retrieval of viable cells after colony formation when protein or DNA samples are needed.
In the traditional soft agar colony formation assay, cells are grown in a layer of soft agar mixed with cell culture medium that rests on another layer of soft agar, also mixed with cell culture medium, but containing a higher concentration of agar. This prevents cells from adhering to the culture plate, yet allows transformed cells to form visible colonies. The rationale behind this technique is that normal cells depend on cell to extracellular matrix contact to be able to grow and divide. Conversely, transformed cells have the ability to grow and divide irrespective of their surrounding environment. Therefore, cells able to form colonies in an anchorage-independent manner were considered to be transformed and carcinogenic. The overall goal of this method is to measure this capability in cells in a semi-quantitative and stringent manner.
The Wnt signaling pathway is critical in embryogenesis and often de-regulated in tumorigenesis [3] [4] [5] [6] . There are multiple pathways associated with Wnt signaling. The canonical pathway involves Wnt signaling and regulation of downstream gene transcription through its effects on the transcriptional coactivator beta-catenin. Wnts also signal through several non-canonical pathways, for example, the planar cell polarity pathway, which regulates elements involved in cytoskeletal structure 7 , and the Wnt-calcium pathway, which regulates release of calcium from the endoplasmic reticulum 8 . Wnt ligands exert their activity through binding Frizzled receptors. Although several Wnts have been shown to be upregulated in lung cancer, Wnt7a has been shown to be down-regulated in non-small cell lung cancer through promoter methylation 9 . Wnt7a binds Fzd9 and acts as a tumor suppressor through a non-canonical pathway. Restoration of Wnt-7a and Fzd-9 inhibits the growth of non-small cell lung cancer cells 10 . The effects of Wnt7a/Fzd9 are mediated through the activation of ERK-5, which in turn, activates peroxisome proliferatoractivated receptor γ (PPARγ) 11, 12 . Here, we show that overexpression of Wnt7a and Fzd9 results in the suppression of anchorage-independent growth of a murine lung carcinoma cell line. Murine CMT167 cells were derived from a lung carcinoma in C57BL/lcrf mice 13 and were stably 1. Label each well of a tissue culture treated 6-well plate appropriately for each cell line or condition being investigated.
2. Prepare 2x cell culture medium by dissolving 1 g of powder medium and 0.2 g of sodium bicarbonate in de-ionized water to a final volume of 50 ml. 3. Pass this medium through a 0.2 μm filter to sterilize. 4. Add additional components needed for normal culture of the cell line of interest. For example, grow CMT 167 cell line in RPMI 1640 medium supplemented with 10% FBS and 1% penicillin/streptomycin solution. Warm medium to 37 °C in hot water bath prior to use. 5. Prepare 1x cell culture medium separately as you would for normal cell culture of the cell line of interest. 6. Prepare 1% noble agar by adding 1 g of noble agar to 100 ml of deionized water. NOTE: Noble agar will not dissolve completely with agitation alone. 7. Prepare 0.6% noble agar by adding 0.6 g of noble agar to 100 ml of de-ionized water. Both agar solutions can be made in 100 ml glass bottles with closable lids for long-term storage. 8. Autoclave the noble agar mixtures to sterilize. These mixtures can be made in advance and stored at 4 °C but should be heated again at the time of the experiment until agar has completely dissolved. 9. Prepare nitroblue tetrazolium chloride solution by making a 1 mg/ml stock solution in 1x PBS (8 g NaCl, 0.2 g KCl, 1.44 g Na 2 HPO 4 , and 0.24 g KH 2 PO 4 in H 2 O to final volume of 1,000 ml). This will be used at the end of the experiment to stain the colonies.
Plating of Bottom Layer of Agar
1. Loosen the cap on the bottle of 1% noble agar and microwave for about 1-2 min. While heating in a microwave, monitor the solution closely to avoid boiling over. Continue heating, while mixing intermittently, until agar is completely dissolved and the solution is clear. NOTE: Use heat-resistant gloves to handle flask after heating. Failing to do so may cause burn or serious injury. 2. Place melted agar solution and pre-warmed 2x culture medium in an ice bucket filled with hot tap water (42 °C). Also place a 50 ml conical tube in a tube holder in the ice bucket with hot water. Transfer bucket to cell culture hood for subsequent steps. 3. For the bottom layer of agar, you will need 1.5 ml of a mix of agar and medium per well of a 6-well plate. 4. To ensure an adequate amount of the mixture, prepare a total of 12 ml for each 6-well plate. 5. Start by adding 6 ml of culture medium to the 50 ml conical tube and then 6 ml of the 1% noble agar solution. 6. Invert the conical tube several times to mix. Working at a brisk pace will prevent premature hardening of the soft agar. 7. Draw up approximately 5.5 ml of mixture into a 5 ml serological pipette. 8. Allow the air bubbles to rise to top of pipette column before depositing 1.5 ml of this mixture into each well. Use caution to avoid deposition of any air bubbles into the plate wells. 9. Cover the plates and allow agar mixture to solidify at room temperature, in cell culture hood, for 30 min.
Plating the Upper Layer of Agar Containing Cells
1. Once the lower layer of agar has solidified, begin preparation of the upper layer. 2. First, harvest cells by trypsinization and dilute them 1:5 in culture medium (e.g. for 1 ml of trypsin, add 4 ml of medium) into a 15 ml conical tube. 3. Count cells and calculate the number of cells needed per well to prepare a final cell suspension at this time. This number will vary depending on cell type. Use 5,000 cells/well as a starting point and adjust as needed. For this cell number, you would prepare a cell suspension of 6,667 cells/ml (i.e. each well will receive 0.75 ml of this suspension and 0.75 ml of agar for a total volume of 1.5 ml; the concentration of cells will also be diluted 1:2 for a final total cell count of 5,000). 4. The volume of cell suspension needed per well of a 6-well plate will again be 1.5 ml. Prepare additional cell suspension totaling 12 ml per 6-well plate. 5. Melt 0.6% agar solution in a microwave as above and place into ice bucket containing hot water along with a 50 ml conical tube in a tube holder and the final cell suspension from Step 3.3. 6. Transfer the ice bucket with melted 0.6% agar to cell culture hood for subsequent steps. 7. Mix 0.6% agar and cell suspension in a 1:1 ratio, preparing a total volume of 12 ml per 6-well plate. 1.5 ml will be required per well but extra should be made as above. 8. Pipette 6 ml of cell suspension into the 50 ml conical tube. 9. Then, add 6 ml of 0.6% agar to the tube.
NOTE: The temperature of this mixture must be kept around 42 °C to avoid premature hardening and to maximize cell survival. 10. Working quickly, pipette this mixture 2-3x to distribute cells, then draw up 5.5 ml of mixture into a 5 ml serological pipette. 11. Allow any air bubbles to rise to top of pipette column before depositing 1.5 ml of this mixture into each well. Use caution to avoid deposition of any air bubbles into the plate wells. 12. Allow cell/agar mixture to solidify at room temperature, in cell culture hood, for 30 min before placing into a 37 °C humidified cell culture incubator. 13. The time required for adequate colony formation varies for each cell line, typically around 21 days. 14. A layer of growth medium should be maintained over the upper layer of agar to prevent desiccation. 100 μl of medium added twice weekly is sufficient for this purpose.
Representative Results
The expression of Wnt7A and Fzd9 in CMT167 cells is effective in tumor suppression as illustrated by our soft agar colony formation assay. Preliminarily, we used Q-PCR to show that Wnt7A and Fzd9 mRNA are expressed in low levels in CMT167 cells. CMT167 cells showed low levels of endogenous Wnt7A and Fzd9 when compared to MLE-12 cells, an SV40-transformed murine lung epithelial cell line (Figure 1) . We then transfected CMT167 cells with two retroviral overexpression vectors expressing human constructs of Wnt7A (LNCX-Wnt7A) and Fzd9 (LPCX-Fzd9) to create a stable cell line that expresses both Wnt7A and Fzd9 (CMT LL Wnt7a/Fzd9). We confirmed expression of Wnt7A and Fzd9 by Q-PCR in this cell line (Figure 2 ). As our previous work has shown, PPARγ is a downstream effector of Wnt7A/Fzd9 signaling. Wnt signaling pathways are diverse. Therefore, proper expression and activation of a particular Wnt and its Fzd receptor must be assessed using a downstream effector that is known to be activated by the Wnt/Fzd pair of interest. For Wnt7A and Fzd9, PPARγ was chosen for this reason. We transfected CMT167 cells overexpressing empty vectors (LNCX/LPCX) or Wnt7A/Fzd9 with a Luciferase reporter construct containing a PPARγ response element. We showed that our CMT167 LL Wnt7A/Fzd9 cell line had almost six-fold increased PPAR-RE activity (Figure 3) . Finally, as mentioned previously, to confirm the tumor suppressor activity of Wnt7A and Fzd9 in vitro, we performed a soft agar colony formation assay. CMT167 vector expressing and Wnt7A/Fzd9 expressing stable cell lines were plated onto soft agar plates and allowed to form colonies for two to three weeks. CMT167 LL Wnt7A/Fzd9 cells formed significantly less colonies when compared to vector-transfected cells, illustrating the tumor suppressor function of Wnt7A and Fzd9 (Figure 4 ). Pictures were taken of all plates, and colonies were counted using an imager and imaging software. 
